Zim Laboratories Stock Screener | Share Price & Fundamental Analysis
ZIMLAB
Pharmaceuticals
Share Price NSE
₹67.22
▼
-0.25 (-0.37%)
Share Price BSE
₹67.35
▼
-0.22 (-0.33%)
Track Zim Laboratories share price live with TickJournal's free stock screener.
Analyze Zim Laboratories share price history trends and compare 52-week high low
levels.
Calculate ZIMLAB stock fair value using fundamental analysis and view live share price charts.
Determine Zim Laboratories share intrinsic value and compare it with current ZIMLAB share price.
Record your Zim Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Zim Laboratories Market Cap
₹343.13 Cr.
ZIMLAB P/E Ratio (TTM)
15.00
EPS (TTM)
₹2.50
Dividend Yield
-
Debt to Equity
0.47
ZIMLAB 52 Week High
₹120.82
Zim Laboratories 52 Week Low
₹66.68
Operating Margin
13.00%
Profit Margin
4.55%
ZIMLAB Revenue (TTM)
₹110.00
EBITDA
₹16.00
Net Income
₹5.00
Total Assets
₹472.00
Total Equity
₹252.00
Zim Laboratories Share Price History - Stock Screener Chart
Screen ZIMLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Zim Laboratories Company Profile - Fundamental Screener
Screen Zim Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ZIMLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE518E01015
Zim Laboratories Balance Sheet Screener
Screen ZIMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 472 | 447 | 342 | 342 | 325 | 325 | 329 | 298 | 259 | 256 |
| Current Assets | 231 | 228 | 191 | 212 | 192 | 182 | 194 | 173 | 154 | 154 |
| Fixed Assets | 164 | 161 | 109 | 106 | 107 | 116 | 106 | 94 | 89 | 92 |
| Liabilities | ||||||||||
| Total Liabilities | 472 | 447 | 342 | 342 | 325 | 325 | 329 | 298 | 259 | 256 |
| Current Liabilities | 53 | 49 | 30 | 20 | 22 | 28 | 22 | 20 | 28 | 35 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 252 | 239 | 200 | 176 | 161 | 154 | 151 | 137 | 118 | 99 |
| Share Capital | 49 | 49 | 49 | 16 | 16 | 16 | 16 | 8 | 8 | 8 |
| Reserves & Surplus | 202 | 190 | 152 | 160 | 145 | 138 | 135 | 129 | 110 | 91 |
Zim Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Zim Laboratories income statement and profit fundamentals.
Analyze ZIMLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Zim Laboratories share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 110 | 73 | 91 | 119 | 83 | 94 | 98 | 106 | 69 | 87 | 97 | 107 | 95 | 101 | 103 |
| Expenses | 94 | 68 | 83 | 102 | 74 | 83 | 85 | 90 | 63 | 77 | 85 | 90 | 82 | 87 | 88 |
| EBITDA | 16 | 6 | 8 | 17 | 9 | 11 | 13 | 16 | 6 | 11 | 13 | 16 | 13 | 14 | 16 |
| Operating Profit % | 13.00% | 6.00% | 6.00% | 13.00% | 10.00% | 10.00% | 12.00% | 15.00% | 7.00% | 11.00% | 12.00% | 14.00% | 12.00% | 12.00% | 13.00% |
| Depreciation | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Interest | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 8 | -2 | 0 | 11 | 1 | 3 | 6 | 10 | 0 | 5 | 7 | 11 | 8 | 8 | 10 |
| Tax | 3 | -1 | 0 | 3 | 0 | 1 | 2 | 3 | 0 | 1 | 2 | 4 | 2 | 3 | 3 |
| Net Profit | 5 | -2 | 0 | 8 | 1 | 2 | 4 | 7 | 0 | 4 | 5 | 7 | 5 | 5 | 7 |
| EPS | 1.01 | -0.38 | -0.09 | 1.66 | 0.18 | 0.49 | 0.82 | 1.48 | 0.05 | 0.85 | 0.98 | 4.33 | 3.17 | 3.35 | 1.35 |
Zim Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ZIMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 41 | 16 | 38 | 49 | 32 | 22 | 35 | 37 | 32 | 22 |
| Investing Activities | -40 | -73 | -36 | -14 | -6 | -19 | -21 | -26 | -7 | -12 |
| Financing Activities | -9 | 60 | 1 | -33 | -26 | -2 | -15 | -10 | -25 | -10 |
| Net Cash Flow | -8 | 3 | 3 | 2 | 0 | 1 | -1 | 1 | 0 | 0 |
Zim Laboratories Shareholding Pattern Screener
See Zim Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Zim Laboratories promoter holding and ownership changes for ZIMLAB on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% | 33.26% |
| FII Holding | 0.01% | 0.03% | 0.00% | 0.01% | 0.00% | 0.00% | 0.21% | 0.00% |
| DII Holding | 0.24% | 0.24% | 0.24% | 0.00% | 0.11% | 0.10% | 0.24% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 47.78% | 47.50% | 48.20% | 49.01% | 49.21% | 45.48% | 44.39% | 51.57% |
| Other Holding | 18.71% | 18.96% | 18.30% | 17.72% | 17.42% | 21.15% | 21.90% | 15.16% |
| Shareholder Count | 17,448 | 16,641 | 17,282 | 17,100 | 17,483 | 17,716 | 17,450 | 5,879 |
Zim Laboratories Share Dividend Screener - Share Yield Analysis
Check Zim Laboratories dividend history with payout and yield data.
View Zim Laboratories dividend details including ex-dates and amounts for ZIMLAB stock.
Zim Laboratories Stock Index Membership
See which indices include Zim Laboratories stock.
Check ZIMLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Zim Laboratories Market Events Screener - Corporate Actions
Get Zim Laboratories corporate actions including splits, bonuses, and buybacks.
Check Zim Laboratories stock events that may affect ZIMLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 5.86% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -29.01% |
| 2025-06-27 | 2025-06-27 | Annual General Meeting | NA | 27.77% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 5.18% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 5.61% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 5.94% |
| 2024-06-27 | 2024-06-27 | Annual General Meeting | NA | 2.64% |
| 2022-12-22 | 2022-12-22 | Bonus | 2:1 | 5.37% |
| 2022-06-29 | 2022-06-29 | Extraordinary General Meeting | NA | -18.24% |
| 2018-10-04 | Bonus | 1:1 | - |
Zim Laboratories Competitors Screener - Peer Comparison
Screen ZIMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Zim Laboratories Company Announcements - News Screener
Screen ZIMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Results- Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2025 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-05 | Board Meeting Intimation for Considertaion And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |